Schizophrenia News

New Study Suggests Clinical Benefits Of Risperdal R ConstaTM In Patients With Recent Onset Psychosis

Mon, 23 Jun 2008 02:00:06 GMT

Patients with psychosis treated early on in the course of their illness with Risperdal ConstaTM (risperidone long-acting injection), demonstrated high response and remission rates with low relapse rates according to a preliminary study published in the April edition of the Journal of Clinical Psychopharmacology.

Full text

Antipsychotic Drugs Increase Risk Of Developing Pneumonia In Elderly - Nursing Home Patients At Particular Risk

Mon, 23 Jun 2008 02:00:05 GMT

Elderly patients who use antipsychotic drugs have a 60 percent increased risk of developing pneumonia compared to non-users.

Full text

Mental Health Research Charity Honours Dr. Mei For Schizophrenia Studies

Mon, 23 Jun 2008 02:00:05 GMT

Studies of how brain cell communication may be altered in schizophrenia have earned Dr. Lin Mei, chief of developmental neurobiology at the Medical College of Georgia, a 2008 Distinguished Investigator Award from NARSAD.

Full text

Brain Chemical Imbalance May Explain Lack Of Motivation In Schizophrenia

Mon, 23 Jun 2008 02:00:04 GMT

A study of patients with psychotic illnesses such as schizophrenia suggests an alternative explanation for why many sufferers lack motivation.

Full text

New Link To Schizophrenia Discovered By Hopkins Researchers

Mon, 23 Jun 2008 02:00:03 GMT

Neuroscientists at Johns Hopkins have discovered that mice lacking an enzyme that contributes to Alzheimer disease exhibit a number of schizophrenia-like behaviors.

Full text

Schizophrenia - Risperidone Long-Acting Injection Extends Time To Relapse Compared To Oral Quetiapine

Sat, 21 Jun 2008 22:40:10 GMT

A new study, presented for the first time at an international psychiatric meeting, examined the time to relapse in patients with schizophrenia treated with risperidone long-acting injection (RLAI) or oral quetiapine.

Full text

Patients Treated With Risperidone Long Acting Injection Had A Significantly Longer Time To Relapse Compared To Quetiapine In Clinical Study

Fri, 20 Jun 2008 18:40:05 GMT

Nearly half of patients with schizophrenia fail to remain on their medication treatment, which can result in a relapse of symptoms (1, 2).

Full text

Pharmacogenetic Findings May Lead To Individualized Treatment For Schizophrenia

Fri, 20 Jun 2008 18:40:04 GMT

Data presented at the APA Annual Meeting on Vanda Pharmaceuticals Inc.'s (NASDAQ: VNDA) investigational drug candidate, iloperidone, included its 4-week, short-term Phase III trial, as well as a pooled analysis of three long-term, 52-week trials, studying the efficacy and safety of iloperidone.

Full text

Abnormalities Found In Specific Brain Area Of Recently Diagnosed Schizophrenia Patients

Thu, 19 Jun 2008 15:20:07 GMT

Patients recently diagnosed with schizophrenia have abnormalities in a specific part of the brain's white matter.

Full text

Teva Receives Court Ruling Awarding Exclusivity For Generic Risperdal R

Thu, 19 Jun 2008 15:20:06 GMT

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the District of Columbia has granted a request of the Company's subsidiary, Teva Pharmaceuticals USA, Inc.

Full text